Fmoc-L-azetidine-2-carboxylic acid

Fmoc-L-azetidine-2-carboxylic acid is an Fmoc-protected L-azetidine amino acid derivative in which the amino functionality is masked by the fluorenylmethoxycarbonyl group while the ring bears a carboxylic acid at the 2-position. The azetidine ring introduces a compact, conformationally constrained, stereodefined scaffold that can influence peptide backbone geometry and side-chain orientation relative to conventional amino acids. The molecule contains an Fmoc carbamate and a free carboxylic acid, enabling standard protected-amino-acid handling for coupling chemistry while supporting downstream transformations of the carboxyl group. The chiral center associated with the L-configuration and the rigid heterocycle make it a practical intermediate for stereocontrolled peptide construction and for generating peptidomimetic analogs with altered conformational properties.

1. Peptide Synthesis

Fmoc-L-azetidine-2-carboxylic acid serves as a protected amino acid building block for solid-phase peptide synthesis and solution-phase peptide coupling. The Fmoc group provides orthogonal temporary protection of the amino functionality, while the carboxylic acid participates in amide bond formation under peptide coupling conditions. The azetidine ring can be incorporated as a constrained residue to modulate local backbone torsion angles and side-chain presentation in peptide analogs. Resulting azetidine-containing peptides can be used to probe sequence-dependent conformational effects and to generate libraries of constrained peptidomimetics for research and method development in peptide chemistry.

2. Peptidomimetics And SAR

Fmoc-L-azetidine-2-carboxylic acid is suitable for peptidomimetic construction in medicinal chemistry workflows that focus on structure-activity relationship studies. The rigid azetidine heterocycle and stereodefined L-configuration can be leveraged to replace more flexible side chains, supporting systematic variation of steric and conformational features across analog series. The Fmoc-protected amino acid format allows incorporation into longer scaffolds, enabling rapid assembly of analog panels through controlled deprotection and coupling cycles. Downstream derivatives prepared from azetidine-containing peptides can be used as SAR substrates to evaluate how constrained geometry affects binding-relevant pharmacophore alignment.

3. Side-Chain Functionalization

Fmoc-L-azetidine-2-carboxylic acid can be employed as a chiral intermediate for side-chain and carboxyl-derived functionalization strategies. The free carboxylic acid enables conversion to activated esters, amides, or other carboxyl derivatives that retain the azetidine stereochemical information. The azetidine ring provides a heterocycle handle that can be carried through functional group interconversions, supporting synthesis of functionalized amino acid derivatives and constrained building blocks for further elaboration. Carboxyl-modified products derived from this intermediate can feed into downstream synthetic routes for specialty fine chemicals and research intermediates used in scaffold diversification.

4. Chemical Biology Labeling

Fmoc-L-azetidine-2-carboxylic acid supports chemical biology and biomolecule modification efforts where constrained amino acid residues are introduced to tune labeling chemistry and molecular recognition. The Fmoc protection enables controlled incorporation into peptides or peptide-like probes, while the carboxyl group can be used to generate conjugation-ready derivatives after assembly. The azetidine ring can influence probe conformation and stability, which may affect how labeled constructs interact with target proteins or binding domains in assay development. The resulting labeled or derivatized peptide constructs can be applied as research tools for studying protein interactions, substrate recognition, and structure-dependent behavior in biochemical systems.

5. Pharmaceutical Intermediate Preparation

Fmoc-L-azetidine-2-carboxylic acid is applicable to pharmaceutical intermediate preparation and process chemistry for manufacturing-related synthesis of constrained amino acid residues and peptide fragments. The Fmoc-protected amino acid format aligns with established industrial peptide-building-block workflows, where orthogonal protection and predictable deprotection behavior support scalable intermediate handling. The molecule's defined stereochemistry and rigid azetidine core make it suitable for producing consistent, stereopure inputs for downstream coupling steps in the synthesis of peptide-based intermediates. Process routes that incorporate this chiral building block can generate azetidine-containing peptide intermediates used in fine chemical production and in the controlled assembly of complex molecular entities.

6. Analytical Standards Development

Fmoc-L-azetidine-2-carboxylic acid can be utilized in analytical research for method development and reference material preparation involving Fmoc-protected amino acid derivatives. The presence of the Fmoc chromophore and the azetidine carboxylic acid provides a structurally distinctive signature for chromatographic and spectrometric characterization of protected amino acid mixtures and peptide hydrolysates. The stereodefined L-configuration supports use as a standard in stereochemical verification workflows for chiral amino acid chemistry and peptide synthesis quality control. Azetidine-containing reference materials derived from this compound can also support calibration and identification of constrained-residue incorporation in peptide and peptidomimetic analysis.

1. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

2. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

4. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die